Pernix Therapeutics Holdings, Inc. (PTX)
-NasdaqGM 3.24 
0.05(1.52%) May 17, 4:00PM EDT
| Prev Close: | 3.29 |
|---|
| Open: | 3.29 |
|---|
| Bid: | N/A |
|---|
| Ask: | 3.77 x 2400 |
|---|
| 1y Target Est: | 7.71 |
|---|
| Beta: | 1.58 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.93 - 3.31 |
|---|
| 52wk Range: | 2.93 - 9.20 |
|---|
| Volume: | 124,554 |
|---|
| Avg Vol (3m): | 75,646 |
|---|
| Market Cap: | 121.48M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.35 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- PERNIX THERAPEUTICS HOLDINGS, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Pernix Reports Loss in 1QZacks(Mon, May 13)
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a DireEDGAR Online(Mon, May 13)
- Pernix Therapeutics Holdings Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- Pernix Therapeutics appoints Michael Pearce as President and CEOtheflyonthewall.com(Fri, May 10)
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- Pernix Therapeutics Reports First Quarter 2013 Financial ResultsBusiness Wire(Fri, May 10)
- Q1 2013 Pernix Therapeutics Holdings Inc Earnings Release - Before Market OpenCCBN(Fri, May 10)
- Pernix Therapeutics to Report First Quarter 2013 Financial Results on May 10, 2013Business Wire(Fri, May 3)
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, FinanEDGAR Online(Thu, Apr 25)
- Pernix Therapeutics to Present at the 12th Annual Needham Healthcare ConferenceBusiness Wire(Tue, Apr 23)
- Pernix Therapeutics Holdings Inc. Stock Downgraded (PTX)at TheStreet(Mon, Apr 22)
- Pernix Reports Loss in 4QZacks(Thu, Mar 21)
- Pernix Therapeutics Holdings Goes Redat Motley Fool(Tue, Mar 19)
- Pike Electric Gets a Thumbs Down and 3 More Analyst Downgrades to Know Aboutat Wall St. Cheat Sheet(Tue, Mar 19)
Reports
- Pernix Therapeutics Holdings Inc: Business description, financial summary, 3yr...Reuters Investment Profile(May 18)
- Industry Value Graph: AEGR , ARIA , HSKA , OSUR , PTX , PRPH , SNTS -- DRUGSFord Investor Services, Inc.(May 17)
- Value Graph: PERNIX THERAPEUT -- PTXFord Investor Services, Inc.(May 17)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.79 |
|---|
| Ex-Dividend Date: | 21-Aug-01 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.38 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.10 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | -0.36 |
|---|
Business Summary
Pernix Therapeutics Holdings, Inc. focuses on developing, manufacturing, marketing, and selling branded and generic pharmaceutical products for pediatric and adult indications in various therapeutic areas.
View More